The latest market price of bosutinib/bosutinib in 2025

Bosutinib/Bosutinib is an oral tyrosine kinase inhibitor specifically designed to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML). The drug is suitable for use in newly diagnosed adult patients and in patients who have failed to respond to other chronic myelogenous leukemia drugs or who are unable to continue taking these drugs due to side effects. Bosutinib inhibits the proliferation signals of cancer cells by blocking the activity of abnormal proteins, thereby effectively delaying the spread of cancer cells.

In terms of medication, bosutinib is usually taken in tablet form once a day with food. Patients are recommended to take it at a fixed time to ensure the best effect of the drug. During medication, be sure to follow the doctor's advice and do not adjust the dosage at will. At the same time, the tablets should be swallowed whole and do not cut, chew or crush. If the tablet is broken, avoid direct contact with your hands. The doctor will promptly adjust the dosage or consider whether to stop treatment based on the patient's treatment response and side effects. Even if patients feel well, they must continue to take bosutinib on time to ensure stable efficacy.

As of now, the original drug of bosutinib has not been officially launched in the Chinese market, so the specific domestic selling price is still unknown. However, in overseas markets, the prices of the Swiss, Turkish and European versions of bosutinib’s original drug are different. Taking the Turkish version as an example, the price of 500mg*28 tablets is about more than 2,000 RMB, while the European and Swiss versions may cost close to 40,000 RMB (the price will be affected by exchange rate fluctuations).

In addition, bosutinib generics from other countries are also circulating in the market. The ingredients of these generics are similar to the original drugs. For example, bosutinib produced in India is produced in 100mg*120 tablets, and the price may be more than 1,000 yuan (also affected by exchange rate fluctuations). In comparison, generic drugs are more attractively priced, providing patients with more choices.

Reference materials:https://medlineplus.gov/druginfo/meds/a613005.html